What are the current guidelines for the use of anticoagulation in patients with atrial flutter?
Fuente:
Zenodo
Guardado en:
| Autor principal: | |
|---|---|
| Formato: | Recurso digital |
| Publicado: |
Zenodo
2026
|
| Materias: | |
| Acceso en línea: | |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| _version_ | 1866901838888960000 |
|---|---|
| author | Tripdatabase |
| author_facet | Tripdatabase |
| contents | The evidence suggests that anticoagulation management in atrial flutter mirrors that for atrial fibrillation, focusing on patients with elevated CHA2DS2-VASc scores and utilizing NOACs as the preferred therapy option. |
| format | Recurso digital |
| id | zenodo_https___doi_org_10_5281_zenodo_18318955 |
| institution | Zenodo |
| language | |
| publishDate | 2026 |
| publisher | Zenodo |
| record_format | zenodo |
| spellingShingle | What are the current guidelines for the use of anticoagulation in patients with atrial flutter? Tripdatabase anticoagulation atrial flutter guidelines cardiology long-term management The evidence suggests that anticoagulation management in atrial flutter mirrors that for atrial fibrillation, focusing on patients with elevated CHA2DS2-VASc scores and utilizing NOACs as the preferred therapy option. |
| title | What are the current guidelines for the use of anticoagulation in patients with atrial flutter? |
| topic | anticoagulation atrial flutter guidelines cardiology long-term management |
| url | https://doi.org/10.5281/zenodo.18318955 |